T.D. Poeppel, C. Boy, A. Bockisch, J. Kotzerke, I. Buchmann, S. Ezziddin, K. Scheidhauer, B.J. Krause, D. Schmidt, H. Amthauer, F. Rösch, J. Nagarajah,
D. Führer, H. Lahner, G. Pöpperl, D. Hörsch, M.A. Walter, R.P. Baum.
Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1).
Nuklearmedizin. 2015 Feb 16;54(1):1-11.

F. Rösch, R.P. Baum.
Generator-based PET radiopharmaceuticals for molecular imaging of tumours: On the way to THERANOSTICS
Dalton Transactions 40/23 (2011) 6104-6111

H. Uusijärvi, P. Bernhardt, H. Mäcke, F. Rösch, E. Forssell-Aronsson.
Electron and positron-emitting radiolanthanides for therapy – A dosimetric and production evaluation
J Nucl Med 47 (2006) 807-814.


H.-G. Buchholz, H. Herzog, G.J. Förster, H. Reber, O. Nickel, F. Rösch, P. Bartenstein.
PET Imaging with Yttrium-86: Comparison of phantom measurements acquired with different PET scanners before and after applying
background subtraction
Eur J Nucl Med, 30 (2003) 716-720


T. Reischl, F. Rösch, H.-J. Machulla.
Electrochemical separation and purification of yttrium-86
Radiochim Acta, 90 (2002) 225-228


G.J. Förster, M. Engelbach, J. Brockmann, H. Reber, H-G. Buchholz, HR. Mäcke, F. Rösch, H. Herzog, P. Bartenstein.
Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours:
comparison of ⁸⁶Y-DOTATOC and 111In-DTPA-octreotid
Eur J Nucl Med, 28 (2001) 1743-1750


J. Brockmann, F. Rösch.
Determination of stability constants in Y-DTPA-peptide-systems: Evaluation of a radiochemical method using n.c.a. yttrium-88
Radiochim Acta, 87 (1999) 79-85


F. Rösch, H. Herzog, B. Neumaier, H.W. Müller-Gärtner, G. Stöcklin.
Quantitative whole-body pharmacokinetics of Yttrium-86 complexes with PET and radiation dose calculation of analogous Yttrium-90 radiotherapeuticals. „Sixth International Radiopharmaceutical Dosimetry Symposium“ Gatlinburg
Tennessee (1999) Conference proceedings pp 101-110


F. Rösch, H. Herzog, B. Stolz, J. Brockmann, M. Köhle, H. Mühlensiepen, P. Marbach, H.W. Müller-Gärtner.
Uptake kinetics of the somatostatin receptor ligand [⁸⁶Y]DOTA-DPhe¹-Tyr³-octreotide ([⁸⁶Y]SMT 487) using positron emission tomography
in non-human primates and calculation of radiation doses of the ⁹⁰Y-labelled analogue
Eur J Nucl Med, 26 (1999) 358-366


B. Neumaier, F. Rösch.
Ternary complex formation between yttrium, phosphate and serum proteins: Physicochemical state of yttrium in blood
Radiochim Acta, 81 (1998) 171-177


H.J. Wester, J. Brockmann, F. Rösch, B. Stolz, W. Wutz, H. Herzog, P.M. Smith-Jones, C. Bruns, G. Stöcklin.
Quantitative in vivo uptake kinetics of ¹⁸F-octreotide measured by PET: A comparison with ⁸⁶Y-DTPA-octreotide and ⁶⁸Ga-DFO-octreotide
in tumor bearing rats
Nucl Med Biol, 24 (1997) 275-286


J. Brockmann, F. Rösch, H. Herzog, H. Mühlensiepen, M. Köhle, B. Stolz, P. Marbach, H.W. Müller-Gärtner.
Complexation, in vivo-stability, blood clearance and excretion kinetics of ⁸⁶Y-DOTA-Tyr³-octreotide in baboons
J Label Compd Radiopharm, 39 (1997) 468-470


J. Brockmann, F. Rösch.
Determination of stability constants in Y-DTPA-peptide systems: Evaluation of a radiochemical method using n.c.a. yttrium-88
J Label Compd Radiopharm, 39 (1997) 471-473


F. Rösch, H. Herzog, C. Plag, B. Neumaier, U. Braun, H.W. Müller-Gärtner, G. Stöcklin.
Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission
tomography
Eur J Nucl Med, 23 (1996) 958-966


B. Neumaier, F. Rösch.
Binding of radioyttrium to human serum albumin: Relevance to endotherapeutic applications of ⁹⁰Y-labelled pharmaceutics
J Label Compd Radiopharm, 37 (1995) 569-570


J. Brockmann, F. Rösch.
Labelling of small peptides with yttrium and gallium via a new DOTA-derivative or DFO using different disuccinimidylic esters as linker
J Label Compd Radiopharm, 37 (1995) 516-518


J. Brockmann, F. Rösch, H. Herzog, B. Stolz, C. Bruns, G. Stöcklin.
In vivo uptake kinetics and dosimetric calculations of ⁸⁶Y-DTPA-octreotide with PET as a model for potential endotherapeutic octreotides
labeled with ⁹⁰Y
J Label Compd Radiopharm, 37 (1995) 519-521


S.M. Qaim, M. Uhl, F. Rösch, F. Szelec`senyi.
Excitation functions of (p,α) reactions on ⁶⁴Ni, ⁷⁸Kr, and ⁸⁶Sr
Phys Rev C, 52/2/ (1995) 773-739


F. Rösch, B. Neumaier, G. Stöcklin, S.M. Qaim, H. Herzog, H.W. Müller-Gärtner.
[⁸⁶Y]Citrate and [⁸⁶Y]EDTMP: Preparation, chemical characterization and in vivo quantitation of their pharmacological data with PET
J Label Compd Radiopharm, 35 (1994) 546-548


F. Rösch, S.M. Qaim, G. Stöcklin.
New nuclear data relevant to the production of the positron emitting radioisotope ⁸⁶Y
J Label Compd Radiopharm, 32 (1993) 449-451


F. Rösch, S.M. Qaim, G. Stöcklin.
Production of the positron emitting radionuclide ⁸⁶Y for nuclear medical application
Int J Appl Radiat Isot, 44 /4/ (1993) 677-681


F. Rösch, S.M. Qaim, G. Stöcklin.
Nuclear data relevant to the production of the positron emitting radioisotope ⁸⁶Y via the ⁸⁶Sr(p,n)- and ^natRb(³He,xn)-processes
Radiochim Acta, 61 /1/ (1993) 1-8


H. Herzog, F. Rösch, G. Stöcklin, C. Lueders, S.M. Qaim, L.E. Feinendegen.
Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics
J Nucl Med, 34 (1993) 2222-2226


G.J. Beyer, R. Bergmann, G. Kampf, P. Mäding, F. Rösch.
Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats
Nucl Med Biol, 19 / 2/ (1992) 201-203